Congenital diaphragmatic hernia-associated cardiac dysfunction.
Cardiotonic Agents
/ therapeutic use
Echocardiography
Extracorporeal Membrane Oxygenation
Hernias, Diaphragmatic, Congenital
/ complications
Humans
Hypertension, Pulmonary
/ diagnostic imaging
Infant, Newborn
Lung
/ abnormalities
Plastic Surgery Procedures
Vascular Resistance
Vasodilator Agents
/ therapeutic use
Ventricular Dysfunction
/ diagnostic imaging
Cardiac function
Congenital diaphragmatic hernia
Echocardiography
Pulmonary hypertension
Ventricular function
Journal
Seminars in perinatology
ISSN: 1558-075X
Titre abrégé: Semin Perinatol
Pays: United States
ID NLM: 7801132
Informations de publication
Date de publication:
02 2020
02 2020
Historique:
pubmed:
20
8
2019
medline:
5
3
2021
entrez:
18
8
2019
Statut:
ppublish
Résumé
There is increasing evidence that cardiac dysfunction is a key contributor to CDH pathophysiology. Dysfunction in both right and left ventricles is common in the early neonatal period, contributes to clinical disease severity, and is associated with adverse outcomes including death and ECMO use. Early and routine assessment of ventricular function and pulmonary artery pressure may guide individualized clinical decision-making, including use of pulmonary vasodilators, cardiotropes, ECMO, and timing of surgical repair. Minimizing cardiac dysfunction, whether by prenatal, postnatal or perinatal treatment strategies, may lead to improved outcome in CDH.
Identifiants
pubmed: 31420110
pii: S0146-0005(19)30102-8
doi: 10.1053/j.semperi.2019.07.007
pii:
doi:
Substances chimiques
Cardiotonic Agents
0
Vasodilator Agents
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
151168Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.